Justus Ndukaife, associate professor of electrical and computer engineering and Chancellor Faculty Fellow, and his team have ...

Pfizer has claimed its first regulatory approval for a GLP-1 agonist in obesity, getting a green light in China for ecnoglutide, a once-weekly injectable drug licensed from Hangzhou-based Sciwind ...

Ever since Ozempic started to get prescribed off-label for weight loss, obesity treatment—and our culture at large—has changed. At first, because of the demand, there were shortages. Now, you can get ...

Over 40% of people taking Xenical achieved a 5% decrease in their starting body weight. Saxenda users achieved a 5% decrease in their body weight in more than 63% of cases. Eating a balanced diet and ...